Array Technologies, Inc. (ARRY) Revenue Growth
Array Technologies, Inc. (ARRY) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | -2.22% |
| 2022-12-31 | 91.90% |
| 2023-12-31 | -3.72% |
| 2024-12-31 | -41.91% |
| 2025-12-31 | 40.22% |
How ARRY compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | 47.46% |
| RFL | Rafael Holdings Inc. Class B | 43.96% |
| HROW | Harrow Inc Com | 36.41% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
| ADMA | ADMA Biologics Inc | 19.63% |
These are five companies in the same sector as ARRY with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Array Technologies, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ARRY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARRY | $4.42 | -3.70% | 6.53M |
| 3 | ||||
| 4 | ||||
| 5 |